pipette
ESEspañol

Discontinuation of GLP-1RA Treatment Reinstates Binge-Like Eating and Drives Body Weight Past Pre-Treatment Levels in Mice

B. A. Hildebrandt, S. E. Ahmari

PreprintReal-world use

In the authors' words

We examined the impact of semaglutide treatment and discontinuation in a pre-clinical model for binge eating. Treatment reduced body weight and palatable food intake in mice with binge-like eating. Discontinuation reinstated binge-like eating and caused body weight to significantly exceed pre-treatment baseline, revealing specific binge-related risk when discontinuing GLP-1RAs.

Main resultThe abstract does not state a limitation.

Appeared: Thursday, November 5. bioRxiv. Preprint, not yet peer-reviewed.

DOI: 10.64898/2026.11.02.763781